Gene: REC8
Official Full Name: REC8 meiotic recombination proteinprovided by HGNC
Gene Summary: This gene encodes a member of the kleisin family of SMC (structural maintenance of chromosome) protein partners. The protein localizes to the axial elements of chromosomes during meiosis in both oocytes and spermatocytes. In the mouse, the homologous protein is a key component of the meiotic cohesion complex, which regulates sister chromatid cohesion and recombination between homologous chromosomes. Multiple alternatively spliced variants, encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04966 | REC8 Knockout cell line (HeLa) | Human | REC8 | 1:3~1:6 | Negative | Online Inquiry |
KO04967 | REC8 Knockout cell line (HCT 116) | Human | REC8 | 1:2~1:4 | Negative | Online Inquiry |
KO04968 | REC8 Knockout cell line (A549) | Human | REC8 | 1:3~1:4 | Negative | Online Inquiry |
REC8 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to facilitate the functional analysis of the REC8 gene—a crucial component in mammalian meiosis and gametogenesis. By utilizing CRISPR-Cas9 technology, these cell lines exhibit targeted deletions of the REC8 gene, thus providing an ideal model system for studying its role in chromosomal behavior and fertility.
Key functions of the REC8 Gene Knockout Cell Lines include enabling researchers to investigate the mechanisms of meiosis, DNA repair, and chromosome segregation. The absence of the REC8 protein allows for an in-depth analysis of how its loss affects these vital cellular processes, thereby shedding light on the implications of REC8 mutations in reproductive disorders. By combining traditional cytogenetic techniques with modern molecular biology approaches, scientists can generate valuable insights into the pathways that govern fertility and associated conditions.
The scientific significance of these cell lines extends to both basic research and clinical applications. In a research setting, they provide an essential model for understanding meiotic drive, aneuploidy, and related pathologies, offering a window into the underlying genetics of various reproductive issues. Clinically, these cell lines could be instrumental in developing therapies for infertility or genetic counseling practices linked to chromosomal abnormalities.
Compared to alternative models such as wild-type or non-specific knockouts, the REC8 Gene Knockout Cell Lines present distinct advantages, including higher specificity and more predictable outcomes in gene function studies. By focusing solely on the loss of REC8, researchers can draw clearer conclusions regarding the gene's unique role, minimizing confounding effects from other genetic pathways.
This product is invaluable to researchers and clinicians interested in reproductive biology, genetics, and developmental biology. The potential applications range from pioneering research in gametogenesis to translational studies that could impact clinical fertility treatments.
Our expertise in gene editing and development of genetic products underscores our commitment to providing high-quality resources that empower scientific discovery. Explore the versatility and innovation behind our REC8 Gene Knockout Cell Lines, and leverage them to enhance your research capabilities.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.